Immunization in HIV
| Vaccine | CD4 < 200 cells/µL | CD4 ≥ 200 cells/µL |
|---|---|---|
| Influenza | 1 dose annually (Inactivated Influenza Vaccine) | |
| Tetanus, diphtheria, pertussis (Td/Tdap) | Substitute 1-time dose of Tdap for Td booster; then boost with Td every 10 yrs | |
| Varicella | Contraindicated | 2 doses |
| Human papillomavirus (HPV) | 3 doses through age of 26 yrs | |
| Zoster | Contraindicated | Not Recommended |
| Measles, mumps, rubella (MMR) | Contraindicated | 1 or 2 doses |
| Pneumococcal 13-valent conjugate (PCV13) | 1 dose followed by a booster at 5 yrs | |
| Pneumococcal polysaccharide (PPSV23) | 1 dose | 1 dose |
| Meningococcal | Recommended if some other risk factor is present | |
| Hepatitis A | Recommended if some other risk factor is present | |
| Hepatitis B | 3 doses | 3 doses |
| Haemophilus influenzae type b (Hib) | Recommended if some other risk factor is present | |
| Table adapted from CDC [1] | ||